Embryo Transfer Outcomes After Vitrification With Slush Nitrogen Compared to Liquid Nitrogen
1 other identifier
interventional
253
1 country
1
Brief Summary
The proposed study is a single-blind randomized controlled trial which seeks to characterize implantation rates following embryo vitrification and subsequent warming with both slush nitrogen and liquid nitrogen. After warming, implantation rates and pregnancy outcomes will be assessed.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2020
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 28, 2020
CompletedFirst Posted
Study publicly available on registry
August 3, 2020
CompletedStudy Start
First participant enrolled
September 5, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 3, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 20, 2022
CompletedMay 3, 2023
May 1, 2023
1.7 years
July 28, 2020
May 2, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
sustained implantation rate
fetal heart beat present upon discharge at 8 weeks
approximately 8 weeks gestation age
Secondary Outcomes (3)
clinical pregnancy rate
usually by 5 weeks gestational age
miscarriage rate
1-8 months dependent on gestational age of loss
live birth rate
9 months
Study Arms (2)
Vitrification via slush nitrogen
EXPERIMENTALBlastocyst stage embryos will be vitrified via slush nitrogen
Vitrification via liquid nitrogen
NO INTERVENTIONBlastocyst stage embryos will be vitrified via conventional liquid nitrogen. This is the current standard of care.
Interventions
blastocyst stage embryos will be vitrified via slush nitrogen
Eligibility Criteria
You may qualify if:
- Patients undergoing IVF stimulation cycle with plan for subsequent frozen embryo transfer (FET)
- Patients electing preimplantation genetic testing for aneuploidy (PGT-A)
- Couples electing single embryo transfer (SET)
You may not qualify if:
- All patients who do not voluntarily give their written consent for participation
- Under 18 years old, above 42 years old
- BMI \> 35
- Maximum day 3 Follicle stimulating hormone (FSH) level of 12 or higher
- Anti-mullerian hormone (AMH) level less than 1.0 g/mL, tested within previous year
- Total basal antral follicle count less than 6 follicles
- Failed more than one previous FET cycle
- Use of oocyte donation
- Use of gestational carrier
- Presence of hydrosalpinges that communicate with endometrial cavity
- Diagnosis of endometrial insufficiency: prior cycle with maximal endometrial thickness ≤ 6mm, abnormal endometrial pattern (failure to attain a trilaminar appearance), persistent endometrial fluid
- Uncorrected uterine factor infertility (uterine anomaly, submucosal myomas, uterine septum)
- Single gene disorder chromosomal rearrangement requiring a more detailed embryonic genetic analysis
- Male partner with \<100,000 total motile spermatozoa per ejaculate (donor sperm is acceptable)
- Use of surgical procedures to obtain sperm
- +3 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Reproductive Medicine Assoicates of New Jersey
Basking Ridge, New Jersey, 07920, United States
Related Publications (1)
Klimczak AM, Osman E, Esbert M, Yildirim RM, Whitehead C, Herlihy NS, Hanson BM, Roberts LM, Seli E, Scott RT Jr. A randomized controlled trial comparing embryo vitrification with slush nitrogen to liquid nitrogen in women undergoing frozen embryo transfer: embryology and clinical outcomes. Hum Reprod. 2025 Mar 1;40(3):426-433. doi: 10.1093/humrep/deaf003.
PMID: 39836897DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 28, 2020
First Posted
August 3, 2020
Study Start
September 5, 2020
Primary Completion
May 3, 2022
Study Completion
December 20, 2022
Last Updated
May 3, 2023
Record last verified: 2023-05
Data Sharing
- IPD Sharing
- Will not share